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knockdown seems to impair cell growth and alters cell cycle distri-
bution. An experimental set up, using a RT-PCR based cell cycle
pathway array showed a reproducible up regulation of LOC688900
in rMSC, which encodes Schlafen-1, a protein known as an inducer
of cell cycle arrest in T-lymphocytes and murine ﬁbroblasts.
Conclusions: Based on these knockdown studies we hold a
promising tool for further in vitro analyses and differentiation stud-
ies in MSC. According to the present data, we conclude an involve-
ment of Sox9 in cell cycle progression and thus cell proliferation,




PROLONG THE DELIVERY OF CARTILAGE-INDUCING
GROWTH FACTORS: A PROMISING SYSTEM FOR
STIMULATING SELF-REPAIR OF DAMAGED ARTICULAR
SURFACES
P.P. Srinivasan1, W. Yang1, A. Jha1, X. Jia1,
M.C. Farach-Carson2, C.B. Kirn-Safran1
1Univ. of Delaware, Newark, DE; 2Rice Univ., Houston, TX
Purpose: During the early stages of osteoarthritis (OA), growth
factors with high afﬁnity for both cartilage and bone extracellular
matrix are released and become involved in the repair of lesions.
Recently, bone morphogenetic protein 2 (BMP-2), a growth factor
with heparan sulfate (HS) binding capability, demonstrated an-
abolic cartilage activity when locally administered in the joint space
of OA animal models. Because clearance of small compounds
from the synovial ﬂuid into the lymphatic system is efﬁcient, the
residence time of highly diffusible, unbound cartilage-stimulating
factors such as BMP-2 is extremely limited, and the release of
these factors often is unable to counteract the damaging effects
of proteinases and inﬂammatory cytokines. For this reason, our
goal is to develop a novel delivery system for slow release of
chondrogenic factors to induce local repair of damaged articular
cartilage surfaces and slow the progression of OA.
Methods: The repair potential of perlecan-based bioactive com-
plexes was tested using an in vitro stem cell differentiation system
and an in vivo intra-articular injection method in mice displaying
early signs of knee OA (papain-induced OA model).
Results: We show that a HS-bearing fragment of perlecan cou-
pled to hyaluronan (HA) microparticles prolongs delivery of BMP-2
and supports chondrocyte differentiation in vitro. In addition, pre-
liminary results indicate that proteoglycan depletion is attenuated
when BMP2 is administered in combination with these HS per-
lecan fragment-HA biomatrices.
Conclusions: Perlecan-based growth factor delivering systems
are efﬁcient at inducing chondrogenic differentiation in vitro and
constitute potential novel therapeutic tools for inducing cartilage
self-repair mechanisms in vivo. Ultimately, this new therapeu-
tic strategy is expected to beneﬁt patients by locally inducing
self-regeneration of damaged articular surfaces and preventing
development of irreversible OA symptoms.
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Purpose: Articular cartilage damage has a very low spontaneous
healing capacity. A cell-based therapy with an appropriate source
would offer the opportunity to promote articular cartilage repair.
Stem cells are characterized by their multipotentiality and capacity
for self-renewal and may represent units of active regeneration for
tissues damaged as a result of trauma or disease. Synovium can
be easily harvested. Many attempts have been made to develop a
cell-surface antigen proﬁle for the better puriﬁcation and identiﬁca-
tion of MSCs. However, the identiﬁcation of MSC subpopulations
in culture has been hampered by the lack of appropriate mark-
ers. Thus there is a clear need to develop strategies leading to
the identiﬁcation of potential MSC (sub)population markers. The
objective of this study was to characterize the mixed synovial cell
population (MSCP) and puriﬁed type-B synovial ﬁbroblasts (SFB)
derived from pig synovium by using various known cell-surface
markers and evaluate their chondrogenic differentiation potentials
using a chondrogenic media containing growth factor TGF-β1.
Methods: Cells were isolated from synovium of porcine knee
joints. SF-Bs were negatively isolated by magnetic bead separation
using Dynal CD14.
Flow cytometry analysis was performed with MSCP or SFB
cells. Direct conjugated Ab used for ﬂow cytometry included
anti-CD44-ﬂuorescein isothhiocyanate (FITC), CD90-FITC, CD45-
FITC, CD34-FITC, CD11b-phycoerythrin (PE). Unconjungated Ab
is anti-CD14 and appropriate secondary Ab. Analysis was per-
formed with FlowJo software. 0.5×106 cells were centrifuged at
1000 rpm for 10 minutes. With the supplement of TGF-β1, pellets
were cultured in deﬁned differentiation medium, at 37°C; 5% CO2.
Pellets were harvested for biochemical and histological analyses,
and digested (2 hr at 60°C) in 300 μl papain (125 μg/ml papain, 5
mM cysteine). DNA content was measured via ﬂuorometric assay
using Hoechst 3325. GAG concentration was measured by the
dimethyl-methylene blue dye assay.
Pellets were ﬁxed in 1:1 methanol:acetone solution at 4°C, em-
bedded in parafﬁn, sectioned at 5 μm, and stained with Weigert’s
hemotoxylin and Safranin-O/Fast Green for sulfated GAGs and
immunostained for type II collagen.
Relative mRNA levels of collagenI, II and Aggrecan were deter-
mined by qPCR.
Statistics were performed using one-way ANOVA for at least n=4
where p<0.05 was considered signiﬁcant.
Results: To characterize the mixed synovial cell population and
puriﬁed type-B synovial ﬁbroblasts ﬂow cytometry was performed.
The positive markers in MSCP were CD14, CD44, CD90, cadherin-
11. After puriﬁcation, the macrophage marker CD14 disappeared
Figure 1. Surface molecule proﬁle of the mixed synovial cell population (MSCP)
and puriﬁed type-B synovial ﬁbroblasts (SFB) using ﬂow cytometry.
